CN113929615B - 一种野尻霉素的纯化方法 - Google Patents
一种野尻霉素的纯化方法 Download PDFInfo
- Publication number
- CN113929615B CN113929615B CN202111288086.9A CN202111288086A CN113929615B CN 113929615 B CN113929615 B CN 113929615B CN 202111288086 A CN202111288086 A CN 202111288086A CN 113929615 B CN113929615 B CN 113929615B
- Authority
- CN
- China
- Prior art keywords
- deoxynojirimycin
- filtrate
- eluent
- resin
- purification method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- BGMYHTUCJVZIRP-GASJEMHNSA-N nojirimycin Chemical compound OC[C@H]1NC(O)[C@H](O)[C@@H](O)[C@@H]1O BGMYHTUCJVZIRP-GASJEMHNSA-N 0.000 title description 17
- BGMYHTUCJVZIRP-UHFFFAOYSA-N Nojirimycin Natural products OCC1NC(O)C(O)C(O)C1O BGMYHTUCJVZIRP-UHFFFAOYSA-N 0.000 title description 16
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 claims abstract description 74
- 239000011347 resin Substances 0.000 claims abstract description 45
- 229920005989 resin Polymers 0.000 claims abstract description 45
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 claims abstract description 37
- 238000000855 fermentation Methods 0.000 claims abstract description 32
- 230000004151 fermentation Effects 0.000 claims abstract description 32
- 239000007788 liquid Substances 0.000 claims abstract description 31
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims abstract description 13
- 150000001450 anions Chemical class 0.000 claims abstract description 10
- 150000001768 cations Chemical class 0.000 claims abstract description 9
- 238000002425 crystallisation Methods 0.000 claims abstract description 8
- 230000008025 crystallization Effects 0.000 claims abstract description 8
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 5
- 238000000926 separation method Methods 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 239000000706 filtrate Substances 0.000 claims description 27
- 238000001914 filtration Methods 0.000 claims description 23
- 239000003480 eluent Substances 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- 238000000746 purification Methods 0.000 claims description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 9
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 9
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 125000002091 cationic group Chemical group 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 230000020477 pH reduction Effects 0.000 claims description 4
- 239000005909 Kieselgur Substances 0.000 claims description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 3
- 239000002243 precursor Substances 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000007790 solid phase Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- 238000004042 decolorization Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000011068 loading method Methods 0.000 description 21
- 239000012528 membrane Substances 0.000 description 15
- 239000012535 impurity Substances 0.000 description 11
- 240000000249 Morus alba Species 0.000 description 10
- 235000008708 Morus alba Nutrition 0.000 description 10
- 239000000047 product Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 5
- 239000003957 anion exchange resin Substances 0.000 description 5
- 239000003729 cation exchange resin Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- FVSYPYTVCSNYAS-UHFFFAOYSA-N 2-(hydroxymethyl)-1,2,3,4-tetrahydropyridine-3,4,5-triol Chemical compound OCC1NC=C(O)C(O)C1O FVSYPYTVCSNYAS-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- IMBKASBLAKCLEM-UHFFFAOYSA-L ferrous ammonium sulfate (anhydrous) Chemical compound [NH4+].[NH4+].[Fe+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O IMBKASBLAKCLEM-UHFFFAOYSA-L 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229930000732 piperidine alkaloid Natural products 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111288086.9A CN113929615B (zh) | 2021-11-02 | 2021-11-02 | 一种野尻霉素的纯化方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111288086.9A CN113929615B (zh) | 2021-11-02 | 2021-11-02 | 一种野尻霉素的纯化方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113929615A CN113929615A (zh) | 2022-01-14 |
CN113929615B true CN113929615B (zh) | 2023-06-20 |
Family
ID=79285505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111288086.9A Active CN113929615B (zh) | 2021-11-02 | 2021-11-02 | 一种野尻霉素的纯化方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113929615B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101654428B (zh) * | 2009-09-11 | 2012-05-23 | 成都市金医生科技健康产业有限公司 | 天然产物中提取分离高纯1-脱氧野尻霉素的方法 |
CN102101840B (zh) * | 2011-02-15 | 2012-09-26 | 杭州惠远实业有限公司 | 由桑叶中提取分离高纯度1-脱氧野尻霉素的方法 |
CN103204800B (zh) * | 2013-05-14 | 2017-07-04 | 成都科源生物技术有限公司 | 一种1‑脱氧野尻霉素的提取方法 |
CN111269171B (zh) * | 2020-04-08 | 2023-05-05 | 劲牌持正堂药业有限公司 | 一种高纯度1-脱氧野尻霉素的制备方法 |
CN112094789B (zh) * | 2020-11-10 | 2021-04-06 | 中国科学院天津工业生物技术研究所 | 一种解淀粉芽孢杆菌及其在制备1-脱氧野尻霉素中的应用 |
-
2021
- 2021-11-02 CN CN202111288086.9A patent/CN113929615B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113929615A (zh) | 2022-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107058416B (zh) | 一种精制谷氨酸的发酵工艺 | |
JP2013079224A (ja) | 長鎖ジカルボン酸を純化精製する方法及びその製品 | |
CN107418995B (zh) | 一种石榴皮单宁液态发酵制备的鞣花酸及其制备方法 | |
CN108285913B (zh) | 一种制备提取l-谷氨酰胺的工艺 | |
DD201695A5 (de) | Verfahren zur herstellung von isomaltulose (6-o-alpha-d-gluco-pyranosido-d-fructose) mit hilfe von immobilisierten bakterienzellen | |
CN113004347B (zh) | 一种分离和纯化2’-岩藻糖基乳糖的方法 | |
CN1733668A (zh) | 一种从木糖醇母液中提取木糖醇的方法 | |
CN107201384A (zh) | 一种从d-乳酸钠发酵液中分离提取d-乳酸的方法 | |
CN112047828B (zh) | 一种生物化学法制备原儿茶酸的方法 | |
CN113929615B (zh) | 一种野尻霉素的纯化方法 | |
CN113005161A (zh) | 一种聚唾液酸的制备方法及聚唾液酸制品 | |
JP6164781B2 (ja) | ツラノースを産生する株およびその使用法 | |
CN102703525B (zh) | 一种调节发酵液渗透压提高赤藓糖醇产量的方法 | |
CN102703334B (zh) | 一株产赤藓糖醇的菌株及用其生产赤藓糖醇的方法 | |
CN114195835B (zh) | 一种辅酶ⅰ注射剂原料药制作的新工艺 | |
CN106316836A (zh) | 一种琥珀酸的制备方法 | |
CN113774002B (zh) | 一种解淀粉芽孢杆菌培养基及其应用 | |
CN112125935A (zh) | 一种鼠李糖的制备方法 | |
CN113045610A (zh) | 一种从n-乙酰氨基葡萄糖发酵液中提取氨基葡萄糖的方法 | |
CN110452275B (zh) | 一种高纯度春雷霉素的制备方法 | |
CN113402572A (zh) | 一种精制微生物发酵法制备的氨基葡萄糖复合盐的工艺 | |
CN110862427B (zh) | 一种庆大霉素C1a的纯化方法 | |
CN105254486A (zh) | 一种d-乳酸脱色的新工艺 | |
CN110894521A (zh) | 一种四环素的生产方法 | |
CN109206312A (zh) | 一种从d-乳酸铵发酵液中分离纯化d-乳酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 310011 floor 3, building 94, No. 700, Shixiang Road, Gongshu District, Hangzhou City, Zhejiang Province Applicant after: Zhejiang Hunda Biotechnology Co.,Ltd. Address before: 310000 room d2014-2017, building 2, 452, 6 Baiyang street, Qiantang New District, Hangzhou City, Zhejiang Province Applicant before: Zhejiang Hunda Biotechnology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Purification Method for Nojirimycin Effective date of registration: 20231202 Granted publication date: 20230620 Pledgee: Hangzhou Bank Co.,Ltd. Huanbei Branch Pledgor: Zhejiang Hunda Biotechnology Co.,Ltd. Registration number: Y2023330002894 |